Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs)
Keywords: نفتالیمید; Angiogenesis; Multitarget; Naphthalimide; Topoisomerase II; Tyrosine kinaseEGFR, epidermal growth factor receptor; FGFR, fibroblast growth factor receptor; HMEC-1, Human Microvascular Endothelial Cells; kDNA, kinetoplast DNA; PDGFR, platelet-derived growt